Neuralink Sponsor Identity and Clinical Boundary Record

Neuralink Sponsor Identity and Clinical Boundary Record

Neuralink develops implanted brain-computer-interface systems and sponsors clinical research involving the N1 Implant, R1 Robot, and related software.

The ClinicalTrials.gov PRIME record identifies Neuralink Corp as sponsor and responsible party. The registry is a federal public record, but its study information is supplied by the sponsor. The record should be used for study identity, design, dates, enrollment, eligibility, outcomes, locations, status, and results posting. It does not independently validate favorable outcomes.

Neuralink's clinical-trials page currently presents active device-control and speech-restoration research and an upcoming visual-prosthesis program. Its device-control page links PRIME to computer control and CONVOY to an investigational assistive robotic arm.

The company reported 21 participants across its programs in a January 2026 update. That is a sponsor statement and should not be substituted for the PRIME enrollment field, completed study results, or independent clinical evidence.

Company identity, study sponsorship, and official contact routes are separable from safety or effectiveness. A company profile should route readers to the exact device and study records, state that N1 remains investigational, and label participant stories as sponsor-reported experience.

The public profile should not reproduce private contact information, advise trial participation, imply marketing approval, or generalize one program's status to all Neuralink research.